Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress

Molecular Nutrition and Food Research

Volumn 49, Issue 7, 2005, Pages 685-690

  Lapolla, Annunziata ^a,c   Reitano, Rachele ^a   Seraglia, Roberta ^b   Sartore, Giovanni ^a   Ragazzi, Eugenio ^a   Traldi, Pietro ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

^c Cattedra di Malattie del Metabolismo   (Italy)

Author keywords

Carbonyl compounds; Diabetes; End stage renal disease; Metabolic parameters; Non enzymatic glycation; Peritoneal dialysis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGININE; DIALYSIS FLUID; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; GLYOXAL; LYSINE; METHYLGLYOXAL; PENTOSIDINE;

AGED; BLOOD; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PHYSIOLOGY;

AGED; ARGININE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIALYSIS SOLUTIONS; GLYCOSYLATION END PRODUCTS, ADVANCED; GLYOXAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; LYSINE; MIDDLE AGED; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PYRUVALDEHYDE;

EID: 22444449069     PISSN: 16134125     EISSN: None     Source Type: Journal    
DOI: 10.1002/mnfr.200400093     Document Type: Conference Paper

References (32)

1. Watkins, N. G., Thorpe, S. R., Baynes, I. W., Glycation of amino acid group in proteins. J. Biol. Chem. 1985, 260, 10629-10636.
2. Monnier, V. M., Cerami, A., Nonenzymatic glycosylation and browning of protein in vivo, in: Weller, G. R., Feather, M. S. (Eds.), The Maillard Reaction in Foods and Nutrition. American Chemical Society Series, 1983, pp. 431-499.
3. Thornalley, P. J., Advanced glycation and the development of diabetic complications. Unifying the involvement of glucose, methylglyoxal and oxidative stress. Endocrinol. Metab. 1996, 3, 149-166.
4. Lapolla, A., Traldi, P., Fedele, D., Importance of measuring products of non-enzymatic glycation of proteins. Clin. Biochem. 2005, 35, 103-115.
5. Miyata, T., Ueda, Y., Shinzato, T., Iida, Y., et al., Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J. Am. Soc. Nephrol. 1996, 7, 1198-1206.
6. Sell, D. R., Nagaraj, R. H., Grandhee, S. H., Odetti, P., et al., Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging and uremia. Diabetes Metab. Res. Rev. 1991, 7, 239-251.
7. Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813-820.
8. Miyata, T., van Ypersele de Strihou, C., Kurokawa, K., Baynes, J. W., Alteration in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int. 1999, 55, 389-399.
9. 2 microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: Implications for the pathogenesis of dialysis-related amyloid. J. Clin. Invest. 1996, 98, 1088-1094.
10. Sell, D., Lapolla, A., Odetti, P., Fogarty, J., Monnier, V. M., Pentosidine formation in skin correlates with severity of complications in individual with long-standing IDDM. Diabetes 1992, 47, 1286-1292.
11. Miura, J., Yamagishi, S., Uchigata, Y., Takeuchi, M., et al., Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with type 1 diabetes. J. Diabetes Compl. 2003, 17, 16-21.
12. Tsukahara, H., Sekine, K., Uchiyama, M., Kawakami, H., et al., Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes. Pediatr. Res. 2003, 54, 419-424.
13. Takeuchi, M., Makita, Z., Yanagisawa, K., Kameda, Y., Koike T., Detection of noncarboxymethyl lysine and carboxymethyl lysine advanced glycation end products (AGE) in serum of diabetic patients. Mol. Med. 1999, 5, 393-405.
14. Schiel, R., Franke, S., Appel, T., Voigt, U., et al., Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN). J. Diabetes Compl. 2003, 17, 90-97.
15. Koenig, R. J., Peterson, C. M., Jones, R. L., Saudek, C., et al., Correlation of glucose regulation and haemoglobin A in diabetes mellitus. N. Eng. J. Med. 1976, 295, 417-420.
16. Miyata, T., Ueda, Y., Yoshida, A., Sugiyama, S., et al., Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Kidney Int. 1997, 51, 880-887.
17. Mc Lellan, A. C., Thornalley, P. J., Benn, J., Sonksen, P. H., Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. 1994, 87, 21-29.
18. Schalkwijk, C. G., Posthuma, N., ten Brink, H. J., ter Wee, P. M., Teerlink, T., Induction of 1,2 dicarbonyl compounds, intermediates in the formation of advanced glycation end products, during heat sterilization of glucose-based peritoneal dialysis fluids. Perit. Dial. Int. 1999, 19, 325-333.
19. Ishikawa, N., Miyata, T., Ueda, Y., Inagi, R., et al., Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid. Kidney Int. 2003, 63, 331-339.
20. Peters, A. L., Schriger, D. L., The new diagnostic criteria for diabetes: the impact on management of diabetes and macrovascular risk factor. Am. J. Med. 1998, 105(1A), 15S-19S.
21. Huggett, A., Nixon, D. A., Use of glucose oxidase, peroxidase and o-dianisine in the determination of blood and urine glucose. Lancet 1957, 2, 368-370.
22. Janes, P. K., Willis, M. C., Chon, P. P., Evaluation of minicolumn chromatographic procedure for the measurement of HbA1c. Clin. Biochem. 1985, 18, 32-36.
23. Odetti, P., Fogarty, J., Sell, D. S., Monnier, V. M., Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992, 41, 153-159.
24. Flamini, R., De Luca, G., Di Stefano, R., Changes in carbonyl compounds in Chardonnay and Cabernet Sauvignon wines as a consequence of malolactic fermentation. Vitis 2002, 41, 107-112.
25. Tsukushi, S., Shimokato, K., Niwa, T., GC/MS analysis of erythrocyte 3-deoxyglucosone in hemodialysis patients. J. Chromatogr. B 1999, 731, 37-44.
26. Lapolla, A., Flamini, R., Dalla Vedova, A., Senesi, A., Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin. Chem. Lab. Med. 2003, 41, 1166-1173.
27. Thornalley, P. J., Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int. Rev. Neurobiol. 2002, 50, 37-57.
28. Friedlander, M. A., Wu, Y. C., Elgawish, A., Monnier, V. M., Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis. J. Clin. Invest. 1996, 97, 728-735.
29. Agalou, S., Ahmed, N., Dawnay, A., Thornalley, P. J., Removal of advanced glycation end products in clinical renal failure by peritoneal dialysis and haemodialysis. Biochem. Soc. Trans. 2003, 31, 1394-1396.
30. Ueda, Y., Miyata, T., Goffin, E., Yoshino, A., et al., Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids. Kidney Int. 2000, 58, 2518.
31. Miyata, T., Horie, K., Ueda, Y., Fujita, Y., et al., Advanced glycation and lipoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int. 2000, 58, 425-435.
32. Combet, S., Ferrier, M. L., von Landshoot, M., Stoenoiu, M. S., et al., Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modification in the peritoneum. Am. Soc. Nephrol. 2001, 12, 2146-2157.